Zio AT ECG Monitoring System vs KardiaAI
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose the Zio AT ECG Monitoring System if you require a comprehensive, long-term mobile cardiac telemetry service for continuous and uninterrupted ECG monitoring over several days to weeks. This system is ideal for detecting elusive or infrequent arrhythmias, providing real-time data transmission, and generating detailed, clinician-ready reports for definitive diagnosis and management.
View Zio AT ECG Monitoring System →Choose KardiaAI if…
Choose KardiaAI if you need a powerful, FDA-cleared AI software library for integrating advanced ECG rhythm analysis capabilities into existing medical devices, mobile applications, or web platforms. This tool is best suited for developers or healthcare providers looking to enhance their current ECG solutions with automated detection of common arrhythmias like AFib, bradycardia, and tachycardia.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | KardiaAI |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based for advanced features and services. |
| Deployment | Cloud-based (data analytics and clinician portal) | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemZio AT offers a complete, integrated system with a wearable patch, wireless gateway, and dedicated clinician and patient mobile apps, providing a streamlined, out-of-the-box experience for continuous, long-term monitoring. KardiaAI, as an API library, relies on external integration for its end-user experience, making its direct usability less comprehensive for patients and clinicians.
Clinical Value
Zio AT ECG Monitoring SystemZio AT provides continuous, uninterrupted ECG recording for up to 14 days, which is crucial for detecting intermittent and asymptomatic arrhythmias that might be missed by shorter monitoring periods. Its FDA-cleared deep-learned AI algorithm and comprehensive end-of-wear reports offer a more complete diagnostic picture.
Pricing & Value
KardiaAIKardiaAI offers transparent, publicly disclosed, subscription-based pricing for its integrated services, allowing customers to easily understand and compare costs. Zio AT's pricing is not publicly disclosed and involves service fees, making it harder to assess upfront value without direct engagement.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating strong readiness for healthcare environments. Zio AT provides a complete, cloud-based solution ready for direct deployment, while KardiaAI offers a robust API library for flexible integration into existing enterprise systems.
Innovation
Zio AT ECG Monitoring SystemZio AT's innovation lies in its integrated, continuous, long-term wearable ECG monitoring system, featuring a single patch for up to 14 days of uninterrupted recording and an FDA-cleared deep-learned AI algorithm. This represents a significant advancement in comprehensive ambulatory cardiac monitoring. KardiaAI's innovation is in providing a medical-grade AI library for broad integration, which is impactful but more on the platform side.
Support & Docs
Zio AT ECG Monitoring SystemiRhythm offers 24/7 phone support for both healthcare providers and patients in the US and UK, alongside comprehensive instructions for use and clinical reference manuals. While AliveCor provides extensive documentation and support during business hours, Zio AT's round-the-clock live phone support for both key user groups offers a slight advantage in responsiveness.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | KardiaAI |
|---|---|---|
| Product Name | Zio AT ECG Monitoring System | KardiaAI |
| Company | iRhythm Technologies, Inc. | AliveCor |
| Description | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Core Monitoring/Analysis Type | Continuous, uninterrupted ECG recording for up to 14 days with AI-powered arrhythmia detection. | AI-powered ECG analysis library for detecting cardiac conditions from ambulatory ECG rhythms. |
| Detected Cardiac Conditions | Symptomatic and asymptomatic cardiac events (specific conditions not detailed beyond 'arrhythmia detection') | Atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE) |
| Patient/Clinician Interface | ZioSuiteu00ae clinician portal and mobile app, MyZiou00ae patient mobile app | API library for integration into other ECG devices and software (patient/clinician interface depends on integration) |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or KardiaAI
Backers
Who funded each tool's parent company.